MPJE Drug Recalls, Adverse Event Reporting, and Risk Management 2

Question 1

MedWatch, the FDA Safety Information and Adverse Event Reporting Program, covers which category of products?

Accepted Answer

Human medical products including drugs, biologics, and medical devices

Answer

MedWatch covers all human medical products regulated by the FDA, including prescription drugs, OTC medications, biologics, and medical devices.

Question 2

Drug manufacturers are required to submit expedited adverse event reports to the FDA within how many calendar days for serious and unexpected adverse drug reactions?

Accepted Answer

15 calendar days

Answer

Under 21 CFR 314.81, manufacturers must submit expedited safety reports to the FDA within 15 calendar days for serious and unexpected adverse drug reactions.

Question 3

Which program is specifically designed to monitor adverse events related to vaccines in the United States?

Accepted Answer

VAERS (Vaccine Adverse Event Reporting System)

Answer

VAERS (Vaccine Adverse Event Reporting System) is a national program co-managed by CDC and FDA specifically for monitoring vaccine safety.

Question 4

The FDA Adverse Event Reporting System (FAERS) database is primarily used for which post-market purpose?

Accepted Answer

Post-marketing safety surveillance and pharmacovigilance

Answer

FAERS is used for post-marketing safety surveillance, helping the FDA identify new safety signals and monitor known risks for approved drugs and therapeutic biologics.

Question 5

Which of the following constitutes a 'serious' adverse event under FDA adverse event reporting definitions?

Accepted Answer

An event resulting in death, hospitalization, persistent disability, or congenital anomaly

Answer

Under FDA definitions, a serious adverse event includes outcomes such as death, inpatient hospitalization, persistent or significant disability, congenital anomaly, or other medically important conditions.

MPJE - Multistate Pharmacy Jurisprudence Examination Practice Test

MPJE - Multistate Pharmacy Jurisprudence Examination Practice Test

MPJE Drug Recalls, Adverse Event Reporting, and Risk Management 2